189 related articles for article (PubMed ID: 29569294)
1. Acute myeloid leukemia (AML) with t(7;12)(q36;p13) is associated with infancy and trisomy 19: Data from Nordic Society for Pediatric Hematology and Oncology (NOPHO-AML) and review of the literature.
Espersen ADL; Noren-Nyström U; Abrahamsson J; Ha SY; Pronk CJ; Jahnukainen K; Jónsson ÓG; Lausen B; Palle J; Zeller B; Palmqvist L; Hasle H
Genes Chromosomes Cancer; 2018 Jul; 57(7):359-365. PubMed ID: 29569294
[TBL] [Abstract][Full Text] [Related]
2. t(7;12)(q36;p13) and t(7;12)(q32;p13)--translocations involving ETV6 in children 18 months of age or younger with myeloid disorders.
Slater RM; von Drunen E; Kroes WG; Weghuis DO; van den Berg E; Smit EM; van der Does-van den Berg A; van Wering E; Hählen K; Carroll AJ; Raimondi SC; Beverloo HB
Leukemia; 2001 Jun; 15(6):915-20. PubMed ID: 11417477
[TBL] [Abstract][Full Text] [Related]
3. Trisomy 8 in pediatric acute myeloid leukemia: A NOPHO-AML study.
Laursen AC; Sandahl JD; Kjeldsen E; Abrahamsson J; Asdahl P; Ha SY; Heldrup J; Jahnukainen K; Jónsson ÓG; Lausen B; Palle J; Zeller B; Forestier E; Hasle H
Genes Chromosomes Cancer; 2016 Sep; 55(9):719-26. PubMed ID: 27153159
[TBL] [Abstract][Full Text] [Related]
4. Three-way complex translocations in infant acute myeloid leukemia with t(7;12)(q36;p13): the incidence and correlation of a HLXB9 overexpression.
Park J; Kim M; Lim J; Kim Y; Han K; Lee J; Chung NG; Cho B; Kim HK
Cancer Genet Cytogenet; 2009 Jun; 191(2):102-5. PubMed ID: 19446746
[TBL] [Abstract][Full Text] [Related]
5. High incidence of t(7;12)(q36;p13) in infant AML but not in infant ALL, with a dismal outcome and ectopic expression of HLXB9.
von Bergh AR; van Drunen E; van Wering ER; van Zutven LJ; Hainmann I; Lönnerholm G; Meijerink JP; Pieters R; Beverloo HB
Genes Chromosomes Cancer; 2006 Aug; 45(8):731-9. PubMed ID: 16646086
[TBL] [Abstract][Full Text] [Related]
6. Paediatric B-cell precursor acute lymphoblastic leukaemia with t(1;19)(q23;p13): clinical and cytogenetic characteristics of 47 cases from the Nordic countries treated according to NOPHO protocols.
Andersen MK; Autio K; Barbany G; Borgström G; Cavelier L; Golovleva I; Heim S; Heinonen K; Hovland R; Johannsson JH; Johansson B; Kjeldsen E; Nordgren A; Palmqvist L; Forestier E
Br J Haematol; 2011 Oct; 155(2):235-43. PubMed ID: 21902680
[TBL] [Abstract][Full Text] [Related]
7. [Clinical Efficacy of NOPHO-AML 2004 Regimen for Treatment of Children with Acute Myelocytic Leukemia (Non-M3)].
Qiu KY; Liao XY; Huang K; Li Y; Weng WJ; Xu HG; Fang JP; Wu RH; Zhou DH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Apr; 26(2):375-381. PubMed ID: 29665901
[TBL] [Abstract][Full Text] [Related]
8. Treatment stratification based on initial in vivo response in acute myeloid leukaemia in children without Down's syndrome: results of NOPHO-AML trials.
Lie SO; Abrahamsson J; Clausen N; Forestier E; Hasle H; Hovi L; Jonmundsson G; Mellander L; Gustafsson G
Br J Haematol; 2003 Jul; 122(2):217-25. PubMed ID: 12846889
[TBL] [Abstract][Full Text] [Related]
9. Graft versus leukemia effect after haploidentical HSCT in a MLL-negative infant AML with HLXB9/ETV6 rearrangement.
Hauer J; Tosi S; Schuster FR; Harbott J; Kolb HJ; Borkhardt A
Pediatr Blood Cancer; 2008 Apr; 50(4):921-3. PubMed ID: 17960638
[TBL] [Abstract][Full Text] [Related]
10. Quality of health in survivors of childhood acute myeloid leukemia treated with chemotherapy only: a NOPHO-AML study.
Molgaard-Hansen L; Glosli H; Jahnukainen K; Jarfelt M; Jónmundsson GK; Malmros-Svennilson J; Nysom K; Hasle H;
Pediatr Blood Cancer; 2011 Dec; 57(7):1222-9. PubMed ID: 22095929
[TBL] [Abstract][Full Text] [Related]
11. Characteristics and prognostic factors of acute myeloid leukemia with t (8; 21) (q22; q22).
Lai YY; Qiu JY; Jiang B; Lu XJ; Huang XJ; Zhang Y; Liu YR; Shi HL; Lu DP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Oct; 13(5):733-40. PubMed ID: 16277833
[TBL] [Abstract][Full Text] [Related]
12. Complex and monosomal karyotype are distinct cytogenetic entities with an adverse prognostic impact in paediatric acute myeloid leukaemia. A NOPHO-DBH-AML study.
Bager N; Juul-Dam KL; Sandahl JD; Abrahamsson J; Beverloo B; de Bont ESJM; Ha SY; Jahnukainen K; Jónsson ÓG; Kaspers GL; Kovalova Z; Lausen B; De Moerloose B; Noren-Nyström U; Palle J; Saks K; Zeller B; Kjeldsen E; Hasle H
Br J Haematol; 2018 Nov; 183(4):618-628. PubMed ID: 30406946
[TBL] [Abstract][Full Text] [Related]
13. Renal, gastrointestinal, and hepatic late effects in survivors of childhood acute myeloid leukemia treated with chemotherapy only--a NOPHO-AML study.
Skou AS; Glosli H; Jahnukainen K; Jarfelt M; Jónmundsson GK; Malmros-Svennilson J; Nysom K; Hasle H;
Pediatr Blood Cancer; 2014 Sep; 61(9):1638-43. PubMed ID: 24760750
[TBL] [Abstract][Full Text] [Related]
14. Cytogenetic abnormalities in childhood acute myeloid leukaemia: a Nordic series comprising all children enrolled in the NOPHO-93-AML trial between 1993 and 2001.
Forestier E; Heim S; Blennow E; Borgström G; Holmgren G; Heinonen K; Johannsson J; Kerndrup G; Andersen MK; Lundin C; Nordgren A; Rosenquist R; Swolin B; Johansson B; ; ;
Br J Haematol; 2003 May; 121(4):566-77. PubMed ID: 12752097
[TBL] [Abstract][Full Text] [Related]
15. Pediatric acute myeloid leukemia with t(8;16)(p11;p13), a distinct clinical and biological entity: a collaborative study by the International-Berlin-Frankfurt-Munster AML-study group.
Coenen EA; Zwaan CM; Reinhardt D; Harrison CJ; Haas OA; de Haas V; Mihál V; De Moerloose B; Jeison M; Rubnitz JE; Tomizawa D; Johnston D; Alonzo TA; Hasle H; Auvrignon A; Dworzak M; Pession A; van der Velden VH; Swansbury J; Wong KF; Terui K; Savasan S; Winstanley M; Vaitkeviciene G; Zimmermann M; Pieters R; van den Heuvel-Eibrink MM
Blood; 2013 Oct; 122(15):2704-13. PubMed ID: 23974201
[TBL] [Abstract][Full Text] [Related]
16. Extramedullary leukemia in children with acute myeloid leukemia: A population-based cohort study from the Nordic Society of Pediatric Hematology and Oncology (NOPHO).
Støve HK; Sandahl JD; Abrahamsson J; Asdahl PH; Forestier E; Ha SY; Jahnukainen K; Jónsson ÓG; Lausen B; Palle J; Zeller B; Hasle H
Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28333413
[TBL] [Abstract][Full Text] [Related]
17. Pubertal development and fertility in survivors of childhood acute myeloid leukemia treated with chemotherapy only: a NOPHO-AML study.
Molgaard-Hansen L; Skou AS; Juul A; Glosli H; Jahnukainen K; Jarfelt M; Jónmundsson GK; Malmros J; Nysom K; Hasle H;
Pediatr Blood Cancer; 2013 Dec; 60(12):1988-95. PubMed ID: 24038890
[TBL] [Abstract][Full Text] [Related]
18. Ploidy and clinical characteristics of childhood acute myeloid leukemia: A NOPHO-AML study.
Sandahl JD; Kjeldsen E; Abrahamsson J; Ha SY; Heldrup J; Jahnukainen K; Jónsson OG; Lausen B; Palle J; Zeller B; Forestier E; Hasle H
Genes Chromosomes Cancer; 2014 Aug; 53(8):667-75. PubMed ID: 24753324
[TBL] [Abstract][Full Text] [Related]
19. Use of granulocyte colony-stimulating factor and risk of relapse in pediatric patients treated for acute myeloid leukemia according to NOPHO-AML 2004 and DB AML-01.
Løhmann DJA; Asdahl PH; Abrahamsson J; Ha SY; Jónsson ÓG; Kaspers GJL; Koskenvuo M; Lausen B; De Moerloose B; Palle J; Zeller B; Hasle H
Pediatr Blood Cancer; 2019 Jun; 66(6):e27701. PubMed ID: 30848067
[TBL] [Abstract][Full Text] [Related]
20. Acute myeloid leukemia with t(8;16)(p11.2;p13.3)/KAT6A-CREBBP in adults.
Xie W; Hu S; Xu J; Chen Z; Medeiros LJ; Tang G
Ann Hematol; 2019 May; 98(5):1149-1157. PubMed ID: 30759270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
